Pharosyn
AI-powered commercial intelligence for pharmaceutical teams, turning clinical, regulatory and market signals into traceable reports and decision support.
$3MSeed
ParticipantGA
General Advance
Activity from announced rounds
Activity in this selectionEurope · Seed
General Advance is a private technology investment firm identified in Kairon Health and Pharosyn materials.
Recorded funding activity
Kairon develops execution software for value-based care operations. Pharosyn turns pharmaceutical market and regulatory signals into traceable reports, while Multiplier builds agent systems for asset managers’ research. These businesses serve different professional decisions.
- Rounds participated in
- 1
- Confirmed lead rounds
- 0 All roles disclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $3M 1 disclosed · full round size, not this investor’s share